We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

METCB:NASDAQRamaco Resources, Inc. Analysis

Data as of 2026-05-20 - not real-time

$9.60

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Ramaco Resources is trading near its recent support level with the 20‑day SMA sitting below the 50‑day SMA, a bearish MACD histogram and an RSI around the mid‑30s indicating limited upside momentum. Operating margins are deeply negative and the company carries a debt‑to‑equity ratio above 100%, while free cash flow remains strongly negative. Volatility is elevated at over 40% for the past 30 days and beta exceeds 1.5, suggesting the stock moves sharply with market swings. The dividend yield appears attractive at 7%, but a payout ratio above 800% makes it financially unsustainable.
Recent material news includes a Goldman Sachs upgrade to Neutral and an average one‑year price target of $24.64, implying more than 100% upside, driven by a strategic shift toward rare‑earth and critical mineral development in Wyoming. The upgrade and guidance on Q2 shipments provide a catalyst, yet the sector’s exposure to coal‑related regulatory pressure and the company’s weak balance sheet temper enthusiasm. Investors should weigh the upside potential against the high operational and regulatory risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical indicators (SMA crossover, MACD, RSI)
  • Negative earnings and cash flow
  • Uncertain short‑term catalyst despite upgrade

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Goldman Sachs upgrade and high price‑target upside
  • Progress on rare‑earth project diversifying revenue
  • Potential improvement in cash generation from Q2 shipments

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic shift toward critical minerals reducing coal exposure
  • Long‑term dividend yield attractiveness if payout becomes sustainable
  • Fundamental turnaround potential if debt is reduced and margins improve

Key Metrics & Analysis

Financial Health

Revenue Growth-9.70%
Profit Margin-11.52%
ROE-15.22%
ROA-4.80%
Debt/Equity107.28
P/B Ratio1.5
Op. Cash Flow$-58674000
Free Cash Flow$-97769872

Technical Analysis

TrendBearish
RSI37.7
Support$9.51
Resistance$11.25
MA 20$10.26
MA 50$10.55
MA 200$13.18
MACDBearish
VolumeStable
Fear & Greed Index89.18

Valuation

GradeOvervalued
TypeValue
Dividend Yield7.14%

Risk Assessment

Beta1.61
Volatility43.73%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.